NB97867UV01

CD25/IL-2 R alpha Rat anti-Mouse, DyLight 350, Clone: AP-MAB0710, Novus Biologicals™

Manufacturer: Novus Biologicals

Select a Size

Pack Size SKU Availability Price
Each of 1 NB97867UV01-Each-of-1 In Stock ₹ 60,698.00

NB97867UV01 - Each of 1

₹ 60,698.00

In Stock

Quantity

1

Base Price: ₹ 60,698.00

GST (18%): ₹ 10,925.64

Total Price: ₹ 71,623.64

Antigen

CD25/IL-2 R alpha

Classification

Monoclonal

Conjugate

DyLight 350

Formulation

50mM Sodium Borate with 0.05% Sodium Azide

Gene Symbols

IL2RA

Immunogen

This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a rat immunized with recombinant mouse CD25 protein.

Quantity

0.1 mL

Research Discipline

Adaptive Immunity, Apoptosis, Biologically Active Proteins, Cytokine Research, Diabetes Research, Immunology, Innate Immunity, Mast Cell Markers, Signal Transduction

Gene ID (Entrez)

3559

Content And Storage

Store at 4C in the dark.

Isotype

IgG1

Applications

Flow Cytometry, Immunohistochemistry, Immunohistochemistry (Paraffin)

Clone

AP-MAB0710

Dilution

Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Paraffin

Gene Alias

CD25, CD25 antigen, IDDM10, IL-2 receptor subunit alpha, IL2R, IL-2R subunit alpha, IL-2-RA, IL2-RA, interleukin 2 receptor, alpha, interleukin-2 receptor subunit alpha, p55, TAC antigen, TCGFR

Host Species

Rat

Purification Method

Protein A or G purified

Regulatory Status

RUO

Primary or Secondary

Primary

Target Species

Mouse

Form

Purified

Related Products

Img

Novus Biologicals

NB11097867C

--

Img

Novus Biologicals

NB11097867H

--

Img

Novus Biologicals

NB174727

--

Img

Novus Biologicals

NB174731

--

Img

Novus Biologicals

NBP275902H

--

Img

Novus Biologicals

NB004334

--

Img

Novus Biologicals

NB004317

--

Img

Novus Biologicals

N247725APC7

--

Description

  • CD25/IL-2R alpha Monoclonal specifically detects CD25/IL-2R alpha in Mouse, Rat samples
  • It is validated for Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Paraffin.